Licorice metabolite 18β‐glycyrrhetinic acid activates G protein‐gated inwardly rectifying K+ channels

Author:

Chen I‐Shan1ORCID,Yasuda Jumpei1ORCID,Notomi Takuya1ORCID,Nakamura Tomoe Y.1

Affiliation:

1. Department of Pharmacology, Faculty of Medicine Wakayama Medical University Wakayama Japan

Abstract

Background and PurposeLicorice (liquorice) is a common food additive and is used in Chinese medicine. Excess licorice intake can induce atrial fibrillation. Patients with atrial fibrillation possess constitutively activated G protein‐gated inwardly rectifying K+ (GIRK) channels. Whether licorice affects GIRK channel activity is unknown. We aimed to clarify the effects of licorice ingredients on GIRK current and the mechanism of action.Experimental ApproachA major component of licorice, glycyrrhizic acid (GA), and its metabolite, 18β‐glycyrrhetinic acid (18β‐GA), were tested. We performed electrophysiological recordings in Xenopus oocytes to examine the effects of GA and 18β‐GA on various GIRK subunits (Kir3.1–Kir3.4), mutagenesis analyses to identify the crucial residues for drug action and motion analysis in cultured rat atrial myocytes to clarify effects of 18β‐GA on atrial functions.Key ResultsGA inhibited Kir3.1‐containing channels, while 18β‐GA activated all Kir3.x subunits. A pore helix residue Phe137 in Kir3.1 was critical for GA‐mediated inhibition, and the corresponding Ser148 in Kir3.2 was critical for 18β‐GA‐mediated activation. 18β‐GA activated GIRK channel in a Gβγ‐independent manner, whereas phosphatidylinositol 4,5‐bisphosphate (PIP2) was essential for activation. Glu236 located at the cytoplasmic pore of Kir3.2 appeared to be important to interactions with 18β‐GA. In rat atrial myocytes, 18β‐GA suppressed spontaneous beating via activation of GIRK channels.Conclusion and ImplicationsGA acts as a novel GIRK inhibitor, and 18β‐GA acts as a novel GIRK activator. 18β‐GA alters atrial function via activation of GIRK channels. This study elucidates the pharmacological activity of licorice ingredients and provides information for drug design.

Publisher

Wiley

Subject

Pharmacology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3